Cargando…

Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria

Identification of non-alcoholic steatohepatitis (NASH) with high activity and fibrosis is a major priority in patients with non-alcoholic fatty liver disease. We validated the predictive value of the FibroScan-aspartate aminotransferase (FAST) score and other non-invasive fibrosis surrogates in pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Seung, Lee, Hye Won, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Jang, Jae Young, Park, Soo Young, Lee, Hyun Woong, Lee, Chun Kyon, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048204/
https://www.ncbi.nlm.nih.gov/pubmed/35492369
http://dx.doi.org/10.3389/fmed.2022.869190
_version_ 1784695884425986048
author Lee, Jae Seung
Lee, Hye Won
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Jang, Jae Young
Park, Soo Young
Lee, Hyun Woong
Lee, Chun Kyon
Kim, Seung Up
author_facet Lee, Jae Seung
Lee, Hye Won
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Jang, Jae Young
Park, Soo Young
Lee, Hyun Woong
Lee, Chun Kyon
Kim, Seung Up
author_sort Lee, Jae Seung
collection PubMed
description Identification of non-alcoholic steatohepatitis (NASH) with high activity and fibrosis is a major priority in patients with non-alcoholic fatty liver disease. We validated the predictive value of the FibroScan-aspartate aminotransferase (FAST) score and other non-invasive fibrosis surrogates in predicting high-risk NASH criteria. This multicenter retrospective study recruited 251 biopsy-proven non-alcoholic fatty liver disease (NAFLD) patients (132 [52.6%] men) between 2011 and 2014. The FAST score was calculated using transient elastography data and aspartate aminotransferase (AST) levels. The NAFLD fibrosis score (NFS), fibrosis-4 index (FIB-4), and AST to platelet ratio index (APRI) were calculated using biochemical data. The area under the receiver operating characteristic curves (AUCs) of the FAST score, liver stiffness, NFS, FIB-4, and APRI were 0.752, 0.718, 0.609, 0.650, and 0.722 for NAFLD activity score (NAS) ≥5 (n = 117, 46.6%); 0.788, 0.754, 0.649, 0.701, and 0.747 for fatty liver inhibition of progression-NASH with histologic activity ≥3 (n = 202, 80.5%); 0.807, 0.806, 0.691, 0.732, and 0.760 for severe disease with activity ≥3 and/or fibrosis ≥3 (n = 132, 52.6%); and 0.714, 0.812, 0.748, 0.738, and 0.669 for NASH with NAS ≥4 and fibrosis ≥2 (n = 70, 27.9%), respectively. The FAST score had the highest AUC for the most high-risk NASH criteria, except for in predicting NAS ≥4 and fibrosis ≥2. The liver stiffness value showed consistently acceptable performance in predicting all high-risk NASH criteria. The FAST score has acceptable performance in identifying high-risk NASH. However, liver stiffness alone was not inferior to the FAST score.
format Online
Article
Text
id pubmed-9048204
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90482042022-04-29 Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria Lee, Jae Seung Lee, Hye Won Kim, Beom Kyung Park, Jun Yong Kim, Do Young Ahn, Sang Hoon Jang, Jae Young Park, Soo Young Lee, Hyun Woong Lee, Chun Kyon Kim, Seung Up Front Med (Lausanne) Medicine Identification of non-alcoholic steatohepatitis (NASH) with high activity and fibrosis is a major priority in patients with non-alcoholic fatty liver disease. We validated the predictive value of the FibroScan-aspartate aminotransferase (FAST) score and other non-invasive fibrosis surrogates in predicting high-risk NASH criteria. This multicenter retrospective study recruited 251 biopsy-proven non-alcoholic fatty liver disease (NAFLD) patients (132 [52.6%] men) between 2011 and 2014. The FAST score was calculated using transient elastography data and aspartate aminotransferase (AST) levels. The NAFLD fibrosis score (NFS), fibrosis-4 index (FIB-4), and AST to platelet ratio index (APRI) were calculated using biochemical data. The area under the receiver operating characteristic curves (AUCs) of the FAST score, liver stiffness, NFS, FIB-4, and APRI were 0.752, 0.718, 0.609, 0.650, and 0.722 for NAFLD activity score (NAS) ≥5 (n = 117, 46.6%); 0.788, 0.754, 0.649, 0.701, and 0.747 for fatty liver inhibition of progression-NASH with histologic activity ≥3 (n = 202, 80.5%); 0.807, 0.806, 0.691, 0.732, and 0.760 for severe disease with activity ≥3 and/or fibrosis ≥3 (n = 132, 52.6%); and 0.714, 0.812, 0.748, 0.738, and 0.669 for NASH with NAS ≥4 and fibrosis ≥2 (n = 70, 27.9%), respectively. The FAST score had the highest AUC for the most high-risk NASH criteria, except for in predicting NAS ≥4 and fibrosis ≥2. The liver stiffness value showed consistently acceptable performance in predicting all high-risk NASH criteria. The FAST score has acceptable performance in identifying high-risk NASH. However, liver stiffness alone was not inferior to the FAST score. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9048204/ /pubmed/35492369 http://dx.doi.org/10.3389/fmed.2022.869190 Text en Copyright © 2022 Lee, Lee, Kim, Park, Kim, Ahn, Jang, Park, Lee, Lee and Kim. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lee, Jae Seung
Lee, Hye Won
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Jang, Jae Young
Park, Soo Young
Lee, Hyun Woong
Lee, Chun Kyon
Kim, Seung Up
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title_full Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title_fullStr Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title_full_unstemmed Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title_short Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
title_sort comparison of fibroscan-aspartate aminotransferase (fast) score and other non-invasive surrogates in predicting high-risk non-alcoholic steatohepatitis criteria
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048204/
https://www.ncbi.nlm.nih.gov/pubmed/35492369
http://dx.doi.org/10.3389/fmed.2022.869190
work_keys_str_mv AT leejaeseung comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT leehyewon comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT kimbeomkyung comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT parkjunyong comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT kimdoyoung comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT ahnsanghoon comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT jangjaeyoung comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT parksooyoung comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT leehyunwoong comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT leechunkyon comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria
AT kimseungup comparisonoffibroscanaspartateaminotransferasefastscoreandothernoninvasivesurrogatesinpredictinghighrisknonalcoholicsteatohepatitiscriteria